Injecto Polymers Limited

As of March 31, 2026, Injecto Polymers Limited has 20.79M shares outstanding.

As of March 31, 2026, Injecto Polymers Limited maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 260.79, indicating elevated leverage, while an interest coverage ratio of 3.78 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Injecto Polymers Limited posted a return on equity (ROE) of 28.94, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 12.57 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 12.14, useful for judging operating efficiency across full business cycles. Inventory turnover of 2.95 indicates how many times Injecto Polymers Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Injecto Polymers Limited recorded 74.35M in income tax expense. That works out to an effective tax rate of 31.71, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 234.48M, leaving 160.13M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended March 31, 2026, Injecto Polymers Limited generated 3.76B in revenue and converted that into 160.13M in net income, yielding earnings per share of 7.70. EBITDA reached 380.44M, while operating income came in at 354.28M.

As of March 31, 2026, Injecto Polymers Limited holds 831,000.00 in cash and equivalents against 1.65B in total debt, resulting in a net debt position of 1.65B. Total book value stands at 633.41M, with working capital of 313.21M providing operational flexibility.

Injecto Polymers Limited produced -488.01M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -42.22M in capital expenditures, free cash flow totaled -530.23M - equivalent to -25.50 per share.

Over the twelve months ended March 31, 2026, Injecto Polymers Limited posted a gross margin of 15.85, reflecting its pricing power and cost economics. The operating margin of 9.43 and net profit margin of 4.26 provide insight into operational efficiency.